• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病与非酒精性脂肪性肝病:何时需要引起关注?巴西全国性研究。

Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil.

机构信息

Department of Internal Medicine, Diabetes Unit, State University of Rio de Janeiro (UERJ), Boulevard 28 de Setembro, 77-3º andar-Vila Isabel, Rio de Janeiro-RJ CEP 20551-030, Brazil.

Department of Ophthalmology, State University of Rio de Janeiro (UERJ), Boulevard 28 de Setembro, 77-4º andar-Vila Isabel, Rio de Janeiro-RJ CEP 20551-030, Brazil.

出版信息

Nutrients. 2017 Aug 15;9(8):878. doi: 10.3390/nu9080878.

DOI:10.3390/nu9080878
PMID:28809804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5579671/
Abstract

Obesity is increasing worldwide, affecting even patients with type 1 diabetes (T1D). A higher prevalence of associated comorbidities is expected, such as non-alcoholic fatty liver disease (NAFLD). This paper reports a cross-sectional multicenter study on a population with T1D ( = 1662), which aimed to evaluate the prevalence of metabolic syndrome (MS), a known risk factor for NAFLD, and to investigate predisposing factors associated with MS, as well as factors associated with elevated alanine aminotransferase (ALT), as it correlates to liver fat content. Patients were from 14 public clinics of 10 cities from all geographical regions of Brazil. A high prevalence of MS was found, especially among adults (32.3%), and this was related to age, female gender, acid uric levels, and the presence of acanthosis nigricans. ALT above the normal range was associated with triglyceride levels (especially above 129.5 mg/dL), serum uric acid, age, male gender, HbA1c, and non-Caucasian ethnicity. Patients with T1D, metabolic syndrome, and the aforementioned factors may be at a higher risk of NAFLD and should be referred to ultrasound for NAFLD evaluation. Further studies are necessary to establish the prevalence of NAFLD in individuals with T1D and to determine the disease's progression in these patients.

摘要

肥胖症在全球范围内不断增加,甚至影响到了 1 型糖尿病(T1D)患者。预计会有更多与肥胖相关的合并症,如非酒精性脂肪性肝病(NAFLD)。本文报告了一项针对 T1D 患者(n=1662)的横断面多中心研究,旨在评估代谢综合征(MS)的患病率,MS 是 NAFLD 的已知危险因素,并探讨与 MS 相关的易患因素,以及与丙氨酸氨基转移酶(ALT)升高相关的因素,因为它与肝脂肪含量相关。患者来自巴西 10 个城市的 14 个公共诊所,分布于巴西所有地理区域。研究发现 MS 的患病率很高,尤其是成年人(32.3%),且这与年龄、女性、尿酸水平和黑棘皮病的存在有关。ALT 超过正常范围与甘油三酯水平(尤其是超过 129.5mg/dL)、尿酸、年龄、男性、HbA1c 和非白种人种族有关。患有 T1D、代谢综合征和上述因素的患者可能面临更高的 NAFLD 风险,应转介进行超声检查以评估 NAFLD。有必要开展进一步的研究,以确定 T1D 患者中 NAFLD 的患病率,并确定该疾病在这些患者中的进展情况。

相似文献

1
Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil.1 型糖尿病与非酒精性脂肪性肝病:何时需要引起关注?巴西全国性研究。
Nutrients. 2017 Aug 15;9(8):878. doi: 10.3390/nu9080878.
2
The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.1 型糖尿病儿童和青少年中非酒精性脂肪性肝病的患病率及其危险因素。
J Pediatr. 2021 Mar;230:32-37.e1. doi: 10.1016/j.jpeds.2020.10.043. Epub 2020 Oct 24.
3
Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.新诊断酮症起病糖尿病患者中非酒精性脂肪性肝病的患病率及临床特征。
Diabetes Metab. 2018 Nov;44(5):437-443. doi: 10.1016/j.diabet.2018.03.002. Epub 2018 Mar 21.
4
Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.1型糖尿病儿童和青少年非酒精性脂肪性肝病的筛查:一项横断面分析
Eur J Pediatr. 2017 Apr;176(4):529-536. doi: 10.1007/s00431-017-2876-1. Epub 2017 Feb 17.
5
Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.可改变的临床和生活方式因素与新诊断的 2 型糖尿病患者丙氨酸氨基转移酶水平升高相关:来自全国性 DD2 研究的结果。
Diabetes Metab Res Rev. 2014 Nov;30(8):707-15. doi: 10.1002/dmrr.2539.
6
Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.非酒精性脂肪性肝病(NAFLD)在 1 型糖尿病和 2 型糖尿病患者中的患病率及其与代谢的相关性。
Diabetes Obes Metab. 2017 Nov;19(11):1630-1634. doi: 10.1111/dom.12973. Epub 2017 Jun 22.
7
Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.非酒精性脂肪性肝病与1型糖尿病成年患者远端对称性多发性神经病的患病率增加有关。
J Diabetes Complications. 2017 Jun;31(6):1021-1026. doi: 10.1016/j.jdiacomp.2017.01.024. Epub 2017 Feb 12.
8
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.韩国青少年的正常血清丙氨酸转氨酶与非酒精性脂肪性肝病:一项使用2010 - 2015年韩国国家健康与营养检查调查(KNHANES)数据的横断面研究
BMC Pediatr. 2018 Jul 5;18(1):215. doi: 10.1186/s12887-018-1202-z.
9
Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?苏丹2型糖尿病患者非酒精性脂肪性肝病的患病率及预测因素:代谢综合征是罪魁祸首吗?
Arab J Gastroenterol. 2015 Jun;16(2):54-8. doi: 10.1016/j.ajg.2015.06.001. Epub 2015 Jul 11.
10
Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.学龄儿童非酒精性脂肪性肝病的患病率、危险因素及预测因素:埃及亚历山大市一项基于医院的研究
Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.

引用本文的文献

1
Type 1 diabetes in Brazil: a narrative overview of the Brazilian Type 1 Diabetes Study Group.巴西的1型糖尿病:巴西1型糖尿病研究组的叙述性概述
Diabetol Metab Syndr. 2025 May 24;17(1):166. doi: 10.1186/s13098-025-01708-6.
2
Hyperinsulinemic male LEW.1WR1 rats show early signs of impaired liver metabolism.高胰岛素血症雄性LEW.1WR1大鼠表现出肝脏代谢受损的早期迹象。
Exp Mol Pathol. 2025 Mar;141:104955. doi: 10.1016/j.yexmp.2025.104955. Epub 2025 Feb 11.
3
Liposome Encapsulation Enhances the Antidiabetic Efficacy of Silibinin.脂质体包封增强了水飞蓟宾的抗糖尿病功效。

本文引用的文献

1
Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.非酒精性脂肪性肝病(NAFLD)在 1 型糖尿病和 2 型糖尿病患者中的患病率及其与代谢的相关性。
Diabetes Obes Metab. 2017 Nov;19(11):1630-1634. doi: 10.1111/dom.12973. Epub 2017 Jun 22.
2
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.2002 - 2012年间青少年1型和2型糖尿病的发病率趋势
N Engl J Med. 2017 Apr 13;376(15):1419-1429. doi: 10.1056/NEJMoa1610187.
3
Increasing incidence of type 1 diabetes between 1986 and 2015 in Bauru, Brazil.
Pharmaceutics. 2024 Jun 13;16(6):801. doi: 10.3390/pharmaceutics16060801.
4
Phloretamide Prevent Hepatic and Pancreatic Damage in Diabetic Male Rats by Modulating Nrf2 and NF-κB.根皮苷通过调节 Nrf2 和 NF-κB 预防糖尿病雄性大鼠的肝和胰腺损伤。
Nutrients. 2023 Mar 17;15(6):1456. doi: 10.3390/nu15061456.
5
Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/-Catenin Signaling Pathway.利拉鲁肽通过调节 Wnt/-连环蛋白信号通路减轻链脲佐菌素诱导的糖尿病小鼠肝脏氧化应激、炎症和细胞凋亡。
Mediators Inflamm. 2023 Jan 29;2023:8974960. doi: 10.1155/2023/8974960. eCollection 2023.
6
Do sex differences in paediatric type 1 diabetes care exist? A systematic review.儿童 1 型糖尿病照护中是否存在性别差异?系统综述。
Diabetologia. 2023 Apr;66(4):618-630. doi: 10.1007/s00125-022-05866-4. Epub 2023 Jan 26.
7
Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development.糖尿病 1 型发病中的晚期糖基化终产物与炎症。
Cells. 2022 Nov 4;11(21):3503. doi: 10.3390/cells11213503.
8
Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease.使用不同方法评估非酒精性脂肪性肝病患者肌少症的患病率。
World J Hepatol. 2022 Aug 27;14(8):1643-1651. doi: 10.4254/wjh.v14.i8.1643.
9
Fenugreek Seed Galactomannan Aqueous and Extract Protects against Diabetic Nephropathy and Liver Damage by Targeting NF-κB and Keap1/Nrf2 Axis.胡芦巴籽半乳甘露聚糖水提取物通过靶向NF-κB和Keap1/Nrf2轴预防糖尿病肾病和肝损伤
Toxics. 2022 Jun 30;10(7):362. doi: 10.3390/toxics10070362.
10
Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy.1型糖尿病相关肝病:非酒精性脂肪性肝病与糖原性肝病的鉴别
Front Pharmacol. 2021 Oct 25;12:768576. doi: 10.3389/fphar.2021.768576. eCollection 2021.
巴西包鲁市 1986 年至 2015 年 1 型糖尿病发病率上升。
Diabetes Res Clin Pract. 2017 May;127:198-204. doi: 10.1016/j.diabres.2017.03.014. Epub 2017 Mar 21.
4
Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: The T1D Exchange Clinic Registry.5529例1型糖尿病青少年超重和肥胖的相关因素:T1D交换诊所注册研究
Diabetes Res Clin Pract. 2017 Apr;126:68-78. doi: 10.1016/j.diabres.2017.01.012. Epub 2017 Feb 4.
5
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.美国胃肠病学会临床指南:异常肝功能检查结果的评估
Am J Gastroenterol. 2017 Jan;112(1):18-35. doi: 10.1038/ajg.2016.517. Epub 2016 Dec 20.
6
Adherence to insulin therapeutic regimens in patients with type 1 diabetes. A nationwide survey in Brazil.1型糖尿病患者对胰岛素治疗方案的依从性:巴西全国性调查
Diabetes Res Clin Pract. 2016 Oct;120:47-55. doi: 10.1016/j.diabres.2016.07.011. Epub 2016 Jul 28.
7
Prevalence and comorbidities of double diabetes.双糖尿病的患病率和共病情况。
Diabetes Res Clin Pract. 2016 Sep;119:48-56. doi: 10.1016/j.diabres.2016.06.003. Epub 2016 Jun 25.
8
Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病患者血清尿酸水平与肝脏组织学的关联
Biomed Rep. 2016 Aug;5(2):188-192. doi: 10.3892/br.2016.698. Epub 2016 Jun 1.
9
Diagnosis of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)的诊断
Diabetologia. 2016 Jun;59(6):1104-11. doi: 10.1007/s00125-016-3944-1. Epub 2016 Apr 18.
10
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.